These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

565 related articles for article (PubMed ID: 28887135)

  • 1. Progress in brain targeting drug delivery system by nasal route.
    Khan AR; Liu M; Khan MW; Zhai G
    J Control Release; 2017 Dec; 268():364-389. PubMed ID: 28887135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug Delivery and Targeting to the Brain Through Nasal Route: Mechanisms, Applications and Challenges.
    Kashyap K; Shukla R
    Curr Drug Deliv; 2019; 16(10):887-901. PubMed ID: 31660815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of drug delivery to the brain via nasal route.
    Kozlovskaya L; Abou-Kaoud M; Stepensky D
    J Control Release; 2014 Sep; 189():133-40. PubMed ID: 24997277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal microemulsion for targeted nose to brain delivery in neurocysticercosis: Role of docosahexaenoic acid.
    Shinde RL; Bharkad GP; Devarajan PV
    Eur J Pharm Biopharm; 2015 Oct; 96():363-79. PubMed ID: 26318978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal Drug Delivery: A Non-Invasive Approach for the Better Delivery of Neurotherapeutics.
    Kumar H; Mishra G; Sharma AK; Gothwal A; Kesharwani P; Gupta U
    Pharm Nanotechnol; 2017; 5(3):203-214. PubMed ID: 28521670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier: an excellent platform for brain targeting.
    Pardeshi CV; Belgamwar VS
    Expert Opin Drug Deliv; 2013 Jul; 10(7):957-72. PubMed ID: 23586809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In situ mucoadhesive-thermosensitive liposomal gel as a novel vehicle for nasal extended delivery of opiorphin.
    Mura P; Mennini N; Nativi C; Richichi B
    Eur J Pharm Biopharm; 2018 Jan; 122():54-61. PubMed ID: 29032194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Advances in Intranasal Administration for Brain-Targeting Delivery: A Comprehensive Review of Lipid-Based Nanoparticles and Stimuli-Responsive Gel Formulations.
    Koo J; Lim C; Oh KT
    Int J Nanomedicine; 2024; 19():1767-1807. PubMed ID: 38414526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimuli-responsive In situ gelling system for nose-to-brain drug delivery.
    Agrawal M; Saraf S; Saraf S; Dubey SK; Puri A; Gupta U; Kesharwani P; Ravichandiran V; Kumar P; Naidu VGM; Murty US; Ajazuddin ; Alexander A
    J Control Release; 2020 Nov; 327():235-265. PubMed ID: 32739524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent patents review on intranasal administration for CNS drug delivery.
    Jogani V; Jinturkar K; Vyas T; Misra A
    Recent Pat Drug Deliv Formul; 2008; 2(1):25-40. PubMed ID: 19075895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential of nanoparticulate drug delivery systems by intranasal administration.
    Ali J; Ali M; Baboota S; Sahani JK; Ramassamy C; Dao L; Bhavna
    Curr Pharm Des; 2010 May; 16(14):1644-53. PubMed ID: 20210751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticles for direct nose-to-brain delivery of drugs.
    Mistry A; Stolnik S; Illum L
    Int J Pharm; 2009 Sep; 379(1):146-57. PubMed ID: 19555750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of Noninvasive Drug Delivery Systems to the Brain for the Treatment of Brain/Central Nervous System Diseases].
    Kanazawa T
    Yakugaku Zasshi; 2018; 138(4):443-450. PubMed ID: 29607986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid Nanoparticles for Nasal/Intranasal Drug Delivery.
    Cunha S; Amaral MH; Lobo JMS; Silva AC
    Crit Rev Ther Drug Carrier Syst; 2017; 34(3):257-282. PubMed ID: 28845761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nose to brain transport pathways an overview: potential of nanostructured lipid carriers in nose to brain targeting.
    Selvaraj K; Gowthamarajan K; Karri VVSR
    Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):2088-2095. PubMed ID: 29282995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nose to brain drug delivery - A promising strategy for active components from herbal medicine for treating cerebral ischemia reperfusion.
    Long Y; Yang Q; Xiang Y; Zhang Y; Wan J; Liu S; Li N; Peng W
    Pharmacol Res; 2020 Sep; 159():104795. PubMed ID: 32278035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticle transport across in vitro olfactory cell monolayers.
    Gartziandia O; Egusquiaguirre SP; Bianco J; Pedraz JL; Igartua M; Hernandez RM; Préat V; Beloqui A
    Int J Pharm; 2016 Feb; 499(1-2):81-89. PubMed ID: 26721725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal drug administration: potential for targeted central nervous system delivery.
    Graff CL; Pollack GM
    J Pharm Sci; 2005 Jun; 94(6):1187-95. PubMed ID: 15858850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into direct nose to brain delivery: current status and future perspective.
    Mittal D; Ali A; Md S; Baboota S; Sahni JK; Ali J
    Drug Deliv; 2014 Mar; 21(2):75-86. PubMed ID: 24102636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting.
    Mahajan HS; Mahajan MS; Nerkar PP; Agrawal A
    Drug Deliv; 2014 Mar; 21(2):148-54. PubMed ID: 24128122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.